Literature DB >> 12401315

Iron and infection: competition between host and microbes for a precious element.

J J M Marx1.   

Abstract

During infection microbes attack host tissues, causing damage to specific organs, sepsis or even death. For proliferation microbes desperately need iron for which they have to compete with the host. Micro-organisms have developed an abundant number of strategies to acquire iron from their specific environment and to transport the element to sites of incorporation into biologically important molecules. As part of the non-specific defence mechanisms against infection, the body modifies iron metabolism in order to make iron less available for micro-organisms. Such processes have a profound effect on the immune system and are also expressed in other forms of inflammation. Microbial iron transport systems are explored as targets for antibiotic treatment and vaccines. In particular, iron chelators, used for the treatment of iron overload may become important drugs for fighting bacterial and viral infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401315

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  37 in total

Review 1.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  The influence of iron availability on human salivary microbial community composition.

Authors:  Renke Wang; Aida Kaplan; Lihong Guo; Wenyuan Shi; Xuedong Zhou; Renate Lux; Xuesong He
Journal:  Microb Ecol       Date:  2012-02-09       Impact factor: 4.552

3.  Structure and Metal Binding Properties of Chlamydia trachomatis YtgA.

Authors:  Zhenyao Luo; Stephanie L Neville; Rebecca Campbell; Jacqueline R Morey; Shruti Menon; Mark Thomas; Bart A Eijkelkamp; Miranda P Ween; Wilhelmina M Huston; Bostjan Kobe; Christopher A McDevitt
Journal:  J Bacteriol       Date:  2019-12-06       Impact factor: 3.490

4.  Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.

Authors:  Ana Nunes; Maria Podinovskaia; Andreia Leite; Paula Gameiro; Tao Zhou; Yongmin Ma; Xiaole Kong; Ulrich E Schaible; Robert C Hider; Maria Rangel
Journal:  J Biol Inorg Chem       Date:  2010-04-03       Impact factor: 3.358

5.  Crystallization and preliminary X-ray crystallographic studies of VibE, a vibriobactin-specific 2,3-dihydroxybenzoate-AMP ligase from Vibrio cholerae.

Authors:  Xiuhua Liu; Zhi Wang; Deyu Zhu; Tiandi Wei; Lichuan Gu; Sujuan Xu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-25

6.  Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients.

Authors:  Yan Li; Jinzhi He; Zhili He; Yuan Zhou; Mengting Yuan; Xin Xu; Feifei Sun; Chengcheng Liu; Jiyao Li; Wenbo Xie; Ye Deng; Yujia Qin; Joy D VanNostrand; Liying Xiao; Liyou Wu; Jizhong Zhou; Wenyuan Shi; Xuedong Zhou
Journal:  ISME J       Date:  2014-03-27       Impact factor: 10.302

Review 7.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  Iron deficiency and susceptibility to infections: evaluation of the clinical evidence.

Authors:  G S Tansarli; D E Karageorgopoulos; A Kapaskelis; I Gkegkes; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

Review 9.  Pumping iron: a potential target for novel therapeutics against schistosomes.

Authors:  Amber Glanfield; Donald P McManus; Greg J Anderson; Malcolm K Jones
Journal:  Trends Parasitol       Date:  2007-10-24

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.